{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:41:41Z","timestamp":1772692901334,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"National Funds through FCT\/MCTES","doi-asserted-by":"publisher","award":["UID\/00772\/2025"],"award-info":[{"award-number":["UID\/00772\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Canine splenic hemangiosarcoma is a highly malignant vascular neoplasm and is among the most frequent and clinically relevant splenic tumors in dogs. Its biological behavior is characterized by rapid growth, marked invasiveness, and early metastatic dissemination, contributing to the poor prognosis commonly observed in affected animals. Clinically, splenic hemangiosarcoma often remains subclinical until acute presentation due to splenic rupture and hemoperitoneum, thereby substantially limiting opportunities for early diagnosis and timely therapeutic intervention. Despite advances in diagnostic imaging, surgical techniques, and the use of adjuvant chemotherapy, the impact of current therapeutic approaches on long-term survival remains limited. Splenectomy is primarily palliative for hemorrhage control, and adjuvant doxorubicin-based chemotherapy yields only modest improvements in median survival; alternative approaches (metronomic chemotherapy, immunotherapy, and targeted therapies) have not demonstrated consistent clinical benefit. This review summarizes the biological and pathophysiological features of canine splenic hemangiosarcoma, discusses the main clinical challenges associated with its diagnosis and staging, and critically reviews current therapeutic approaches and their limitations. By integrating biological behavior with clinical and therapeutic evidence, this article highlights the reasons why prognosis remains poor and underscores the need for more effective strategies to improve clinical outcomes in dogs with splenic hemangiosarcoma.<\/jats:p>","DOI":"10.3390\/ani16050778","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:18:45Z","timestamp":1772554725000},"page":"778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Canine Splenic Hemangiosarcoma: Biological Behavior, Clinical Challenges and Therapeutic Limitations"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-8381","authenticated-orcid":false,"given":"Felisbina Pereira","family":"Queiroga","sequence":"first","affiliation":[{"name":"Department of Veterinary Sciences, University of Tr\u00e1s-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal"},{"name":"Animal and Veterinary Research Center (CECAV), University of Tr\u00e1s-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal"}]},{"given":"Ana Margarida","family":"Marques","sequence":"additional","affiliation":[{"name":"Department of Veterinary Sciences, University of Tr\u00e1s-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-2259","authenticated-orcid":false,"given":"Hugo","family":"Greg\u00f3rio","sequence":"additional","affiliation":[{"name":"Animal and Veterinary Research Center (CECAV), University of Tr\u00e1s-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal"},{"name":"Institute for Research and Advanced Training in Health Sciences and Technologies, Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio (CESPU), 4585-116 Gandra, Portugal"},{"name":"AniCura, CHV Porto, 4100-320 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-2419","authenticated-orcid":false,"given":"Gon\u00e7alo N.","family":"Petrucci","sequence":"additional","affiliation":[{"name":"Animal and Veterinary Research Center (CECAV), University of Tr\u00e1s-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal"},{"name":"Institute for Research and Advanced Training in Health Sciences and Technologies, Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio (CESPU), 4585-116 Gandra, Portugal"},{"name":"OneVet Group, Hospital Veterin\u00e1rio do Porto, 3020-210 Porto, Portugal"},{"name":"UNIPRO\u2014Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio (CESPU), 4585-116 Gandra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"ref_1","unstructured":"Maxie, M.G. (2016). Chapter 2\u2014Hematopoietic System. Jubb, Kennedy & Palmer\u2019s Pathology of Domestic Animals: Volume 3, W.B. Saunders. [6th ed.]."},{"key":"ref_2","unstructured":"Nelson, R.W., and Couto, C.G. (2019). Chapter 88\u2014Lymphadenopathy and Splenomegaly. Small Animal Internal Medicine, Elsevier. [6th ed.]."},{"key":"ref_3","unstructured":"Fossum, T.W. (2019). Chapter 23\u2014Surgery of the Hemolymphatic System. Small Animal Surgery, Elsevier. [5th ed.]."},{"key":"ref_4","unstructured":"Zachary, J.F. (2017). Chapter 13\u2014Bone Marrow, Blood Cells, and the Lymphoid\/Lymphatic System. Pathologic Basis of Veterinary Disease, Mosby. [6th ed.]."},{"key":"ref_5","unstructured":"Tobias, K.M., and Johnston, S.A. (2018). Chapter 83\u2014Spleen. Veterinary Surgery Small Animal, Elsevier. [2nd ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Marques, A.M., Petrucci, G., Greg\u00f3rio, H., Lobo, L., Henriques, J., Figueira, A.C., Vilhena, H., Marrinhas, C., and Queiroga, F.L. (2025). Diagnostic and Prognostic Value of Blood Ratios in Canine Splenic Hemangiosarcoma: A Multicentric Observational Study. Vet. Sci., 12.","DOI":"10.3390\/vetsci12040346"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Morris, J., and Dobson, J. (2001). Miscellaneous Tumours. Small Animal Oncology, Blackwell Science.","DOI":"10.1002\/9780470690406"},{"key":"ref_8","first-page":"101","article-title":"Canine Splenic Pathology: A Retrospective Study of 109 Surgical Samples, with Special Emphasis on Fibrohistiocytic Nodules","volume":"7","author":"Bettini","year":"2002","journal-title":"Eur. J. Vet. Pathol."},{"key":"ref_9","unstructured":"Rothrock, K. (2022, July 04). Splenic Neoplasia\u2014Associate Database\u2014VIN. Available online: http:\/\/www.vin.com\/Members\/Associate\/Associate.plx?DiseaseId=647."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1939-1676.2000.tb02262.x","article-title":"Treatment of canine hemangiosarcoma: 2000 and beyond","volume":"14","author":"Clifford","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"ref_11","first-page":"388","article-title":"Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives","volume":"2","author":"Kim","year":"2015","journal-title":"Vet. Sci."},{"key":"ref_12","unstructured":"Ettinger, S.J., Feldman, E.C., and C\u00f4t\u00e9, E. (2017). Chapter 206\u2014Nonneoplastic Diseases of the Spleen. Textbook of Veterinary Internal Medicine, Elsevier."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cvsm.2019.04.009","article-title":"Histiocytic Sarcoma and Hemangiosarcoma Update","volume":"49","author":"Mullin","year":"2019","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Vail, D.M., Thamm, D.H., and Liptak, J.M. (2020). Miscellaneous Tumors-Section A: Hemangiosarcoma. Withrow and MacEwen\u2019s Small Animal Clinical Oncology, Saunders Elsevier.","DOI":"10.1016\/B978-0-323-59496-7.00034-7"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/vco.12574","article-title":"Refining the \u201cdouble two-thirds\u201d rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs","volume":"18","author":"Davies","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1939-1676.1996.tb02085.x","article-title":"Surgery and doxorubicin in dogs with hemangiosarcoma","volume":"10","author":"Ogilvie","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5326\/JAAHA-MS-6540","article-title":"Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma","volume":"53","author":"Matsuyama","year":"2017","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2460\/javma.247.4.393","article-title":"Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001\u20132012)","volume":"247","author":"Wendelburg","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_19","first-page":"967","article-title":"Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005\u20132014)","volume":"59","author":"Batschinski","year":"2018","journal-title":"Can. Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1939-1676.2004.tb00162.x","article-title":"Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma","volume":"18","author":"Sorenmo","year":"2004","journal-title":"J. Vet. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/vco.12139","article-title":"Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma","volume":"15","author":"Finotello","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jsap.12926","article-title":"The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma","volume":"60","author":"Alexander","year":"2019","journal-title":"J. Small Anim. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gardner, H.L., London, C.A., Portela, R.A., Nguyen, S., Rosenberg, M.P., Klein, M.K., Clifford, C., Thamm, D.H., Vail, D.M., and Bergman, P. (2015). Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma. BMC Vet. Res., 11.","DOI":"10.1186\/s12917-015-0446-1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/vco.12548","article-title":"Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma","volume":"18","author":"Treggiari","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1292\/jvms.15-0262","article-title":"Diagnosis of a large splenic tumor in a dog: Computed tomography versus magnetic resonance imaging","volume":"77","author":"Kim","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tamburini, B.A., Phang, T.L., Fosmire, S.P., Scott, M.C., Trapp, S.C., Duckett, M.M., Robinson, S.R., E Slansky, J., Sharkey, L.C., and Cutter, G.R. (2010). Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-619"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Brachelente, C., Torrigiani, F., Porcellato, I., Drigo, M., Brescia, M., Treggiari, E., Ferro, S., Zappulli, V., and Sforna, M. (2024). Tumor Immune Microenvironment and Its Clinicopathological and Prognostic Associations in Canine Splenic Hemangiosarcoma. Animals, 14.","DOI":"10.3390\/ani14081224"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2460\/javma.232.4.553","article-title":"Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003\u20132005)","volume":"232","author":"Hammond","year":"2008","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2460\/javma.258.6.630","article-title":"Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma","volume":"258","author":"Masyr","year":"2021","journal-title":"Javma-J. Am. Vet. Med. Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2460\/javma.239.10.1325","article-title":"Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007\u20132008)","volume":"239","author":"Mallinckrodt","year":"2011","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5326\/JAAHA-MS-5525","article-title":"Treatment with DAV for advanced-stage hemangiosarcoma in dogs","volume":"47","author":"Dervisis","year":"2011","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/jvim.16212","article-title":"Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011\u20132016) and comparison with doxorubicin-based chemotherapy","volume":"35","author":"Faulhaber","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1939-1676.2007.tb03019.x","article-title":"Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs","volume":"21","author":"Lana","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1939-1676.1993.tb01033.x","article-title":"Chemotherapy of Canine Hemangiosarcoma with Doxorubicin and Cyclophosphamide","volume":"7","author":"Sorenmo","year":"1993","journal-title":"J. Vet. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5326\/JAAHA-MS-5954","article-title":"VAC protocol for treatment of dogs with stage III hemangiosarcoma","volume":"49","author":"Alvarez","year":"2013","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1939-1676.1991.tb00943.x","article-title":"Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma","volume":"5","author":"Hammer","year":"1991","journal-title":"J. Vet. Intern. Med."},{"key":"ref_37","first-page":"237","article-title":"Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study","volume":"54","author":"Kahn","year":"2013","journal-title":"Can. Vet. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1939-1676.2000.tb01166.x","article-title":"Evaluation of ifosfamide for treatment of various canine neoplasms","volume":"14","author":"Rassnick","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1476-5810.2003.00024.x","article-title":"Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin","volume":"1","author":"Payne","year":"2003","journal-title":"Vet. Comp. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2460\/javma.231.10.1550","article-title":"Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997\u20132004)","volume":"231","author":"Kim","year":"2007","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jsap.12796","article-title":"Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?","volume":"59","author":"Bray","year":"2018","journal-title":"J. Small Anim. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Petrucci, G.N., Magalh\u00e3es, T.R., Dias, M., and Queiroga, F.L. (2024). Metronomic chemotherapy: Bridging theory to clinical application in canine and feline oncology. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1397376"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lucroy, M.D., Clauson, R.M., Suckow, M.A., El-Tayyeb, F., and Kalinauskas, A. (2020). Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: A preliminary study. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02675-y"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/10611869408996814","article-title":"Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: A progress review","volume":"2","author":"MacEwen","year":"1994","journal-title":"J. Drug Target."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1939-1676.2007.tb02936.x","article-title":"Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma","volume":"21","author":"Biller","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41417-019-0080-3","article-title":"Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma","volume":"26","author":"Konduri","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1939-1676.2000.tb02247.x","article-title":"Canine hemangiosarcoma treated with standard chemotherapy and minocycline","volume":"14","author":"Sorenmo","year":"2000","journal-title":"J. Vet. Intern. Med."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:27:02Z","timestamp":1772688422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/5\/778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ani16050778"],"URL":"https:\/\/doi.org\/10.3390\/ani16050778","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}